中國金典集團(08281.HK)2020年淨利同比增加89.26%至1815.8萬元
格隆匯 3 月 27日丨中國金典集團(08281.HK)公吿,截至2020年12月31日止年度年度業績,收益人民幣3.06億元,同比下降0.51%;年內溢利1815.8萬元,同比增長89.26%;基本每股盈利1.82分;不派息。
年度純利的強勁增長主要歸因於(i)高利潤的家庭衞生產品的快速增長;(ii)從出口以代工生產模式製造的家庭衞生產品方面賺取的出口收入有所增加;(iii)銷售及分銷成有所減少;及(iv)集團認購的財富管理融資產品產生的投資收入有所增加。
另一方面,集團的整體毛利率由去年同期約41.4%增加至年度約43.3%。毛利率增加乃主要由於高利潤產品的比例增加所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.